OVULATION INDUCTION WITH GONADOTROPINS AND INTRAUTERINE INSEMINATION COMPARED WITH IN-VITRO FERTILIZATION AND NO THERAPY - A PROSPECTIVE, NONRANDOMIZED, COHORT STUDY AND METAANALYSIS
Cm. Peterson et al., OVULATION INDUCTION WITH GONADOTROPINS AND INTRAUTERINE INSEMINATION COMPARED WITH IN-VITRO FERTILIZATION AND NO THERAPY - A PROSPECTIVE, NONRANDOMIZED, COHORT STUDY AND METAANALYSIS, Fertility and sterility, 62(3), 1994, pp. 535-544
Objectives: To determine whether one to four cycles of ovulation induc
tion with hMG and IUI or one cycle of IVF results in the highest pregn
ancy rate and is least expensive and whether published pregnancy rates
for one to four cycles of hMG and IUI results in a higher pregnancy r
ate than rates for one cycle of IVF, zygote intrafallopian transfer (Z
IFT), or GIFT. Design: Prospective, nonrandomized, cohort study. Patie
nts were excluded who were infertile for <18 months, had a significant
male factor, had greater than mild endometriosis, or had bilateral no
npatency of the fallopian tubes. Cohort groups included 47 hMG and IUI
patients (99 cycles), 19 IVF patients (19 cycles), and 21 patients (2
10 cycles) receiving no treatment. A meta-analysis on accumulated hMG
and IUI data using similar entry criteria was also performed. Theoreti
cal calculations were performed and stable fecundity assumed to compar
e with national data on IVF, ZIFT, and GIFT. Setting: Fertility Center
, Division of Reproductive Endocrinology, University of Utah, Salt Lak
e City, Utah. Results: A course of therapy with one to four cycles of
hMG and IUI was just as effective as one cycle of IVF in achieving pre
gnancy. No significant difference in pregnancy rates was found between
one IVF cycle and one to four cycles of hMG and IUI in our population
. In vitro fertilization was more expensive than four cycles of hMG an
d IUI. Both IVF and hMG and IUI were more effective than no therapy. P
ublished data also suggest that four cycles of hMG and IUI theoretical
ly result in higher pregnancy rates than one cycle of IVF, ZIFT, or GI
FT. Conclusion: Cost-benefit analysis comparing hMG and IUI, IVF, and
no therapy in infertility patients may favor a course of four cycles o
f hMG and IUI as the first line of therapy. Using meta-analysis and th
eoretical assumptions, the pregnancy rate for one cycle of hMG and IUI
is inferior to IVF, GIFT, or ZIFT; two cycles are comparable to IVF o
r ZIFT and inferior to GIFT; three cycles are superior to IVF or ZIFT
and comparable to GIFT; and four cycles are theoretically superior to
all techniques.